Filter announcements
Loading...
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine, radiology, laboratory, health check-ups and medical services. The company provides its services across 13 cities through its 81 diagnostic centers and 11 reference laboratories.
Vijaya Diagnostic's 24th AGM is set for September 24, 2026, via VC/OAVM. The company has sent web-links to shareholders without registered emails, detailing access to the FY 2025-26 Annual Report online. Update your emails for future communications.
Vijaya Diagnostic Centre announced its 24th Annual General Meeting (AGM) will be held via video conferencing. A record date has been set for dividend entitlement and e-voting. Shareholders can participate electronically.
Vijaya Diagnostic Centre completed distributing proceeds from fractional shares post-Medinova merger. Of ₹0.52 Cr generated, ₹0.15 Cr was paid. ₹0.37 Cr is in escrow for shareholders lacking bank details; VDCL is actively tracing them.
Vijaya Diagnostic Board approved Q2/H1 financial results. It sanctioned Medinova Diagnostic's amalgamation, effective now. Shareholders get 1 Vijaya share (₹1 FV) for 22 Medinova shares (₹10 FV). Authorized capital increased to ₹23.05 Cr, and Medinova Millennium MRI Services LLP became a wholly-owned subsidiary.
Vijaya Diagnostic board approved the financial results for the quarter and half-year. The Medinova amalgamation scheme is now effective, increasing authorized share capital to ₹23.05 Cr. Medinova Millennium MRI Services LLP becomes a wholly-owned subsidiary. Share exchange ratio is 1:22.